EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vacuolar-ATPase inhibitors are antimicrobial agents active against intracellular mycobacteria

Leah Rankine-Wilson iD, Tirosh Shapira iD, Jake Felker iD, Matthew Christofferson, Henok Sahile, Joseph Chao iD, Houria Afshar, Raymond J Andersen, Jim Sun iD, Yossef Av-Gay iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.00478-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Leah Rankine-Wilson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Vacuolar Proton-Translocating ATPases, Mycobacterium tuberculosis. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institute of Health Research, Natural Sciences and Engineering Research Council of Canada, Cystic Fibrosis Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium tuberculosis (Mtb) evades host defenses by inhibiting phagosome acidification in part through the secreted phosphatase PtpA, binding to the vacuolar ATPase (v-ATPase), and disrupting downstream cellular events. We investigated the antimicrobial effects of three v-ATPase inhibitors, Bafilomycin A1 (BafA1), Bafilomycin D, and Cladoniamide B (ClaB), on the growth of Mtb, M. abscessus (Mabs), and M. bovis BCG in THP-1 and murine infection models. We found potent inhibition of intracellular growth with MIC 50 in the nanomolar range, with compounds showing a bacteriostatic inhibition of Mtb growth in THP-1 macrophages. Axenic bacteria were not affected by 2 µM compound in broth, although lysate from macrophages incubated with ClaB resulted in a 50% reduction in bacterial growth in broth, which was further enhanced by the addition of zinc. We further discovered that BafA1 amplifies the cytotoxic effects of Mtb infection and limits Mtb’s ability to delay apoptosis in host cells. BafA1 antimicrobial activity was abolished in Mtb PtpA knockout mutant, and BafA1 binding to PtpA was shown via an in vitro thermal shift assay. Our findings reveal a complex interplay between v-ATPase inhibition, host cell responses, and bacterial survival, challenging traditional views on phagosome acidification in pathogenesis and suggesting novel avenues for host-directed therapies against intracellular mycobacterial infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vacuolar Proton-Translocating ATPasesMycobacterium tuberculosisAnimalsMiceMacrophagesHumansMacrolidesMicrobial Sensitivity TestsMycobacterium bovisMycobacterium abscessusTHP-1 CellsMice, Inbred C57BL

Stichwörter der Autor:innen

Mycobacterium tuberculosisPtpAacidificationbafilomycinhost-directed therapyv-ATPase

Substanzen

Vacuolar Proton-Translocating ATPasesbafilomycin A1Macrolides

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Chemistry, University of British Columbia, Vancouver, British Columbia, Canada.

ORCID-Profile: Leah Rankine-Wilson, Tirosh Shapira, Jake Felker, Joseph Chao, Jim Sun, Yossef Av-Gay

Förderung

  • Canadian Institute of Health Research
  • Natural Sciences and Engineering Research Council of Canada
  • Cystic Fibrosis Canada
  • CIHR

Zitieren

APA

Rankine-Wilson, L., Shapira, T., Felker, J., Christofferson, M., Sahile, H., Chao, J., Afshar, H., Andersen, R. J., Sun, J., & Av-Gay, Y. (2025). Vacuolar-ATPase inhibitors are antimicrobial agents active against intracellular mycobacteria. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00478-25

Vancouver

Rankine-Wilson L, Shapira T, Felker J, Christofferson M, Sahile H, Chao J, et al. Vacuolar-ATPase inhibitors are antimicrobial agents active against intracellular mycobacteria. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00478-25

BibTeX
@article{RankineWilson2025,
  author = {Rankine-Wilson, Leah and Shapira, Tirosh and Felker, Jake and Christofferson, Matthew and Sahile, Henok and Chao, Joseph and Afshar, Houria and Andersen, Raymond J and Sun, Jim and Av-Gay, Yossef},
  title = {Vacuolar-ATPase inhibitors are antimicrobial agents active against intracellular mycobacteria},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.00478-25}
}
Kostenlos starten →